China Biologic Products Announces Effectiveness Of Registration Statement And Mailing Of Definitive Proxy Statement/Prospectus For 2017 Annual Meeting Of Stockholders Post author:Sam Post published:May 21, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018 Ignyta Announces Proposed Public Offering Of Common Stock May 2, 2017 Cambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic January 31, 2018
FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018